Neuralink, a neurotechnology company founded by Elon Musk that is developing implantable brain-computer interfaces, is seeking to raise $500 million in a new round of funding, Bloomberg reported April 23.
People familiar with the matter told the publication that the company has begun early talks with potential investors. Although the details have not been finalized, Neuralink could be valued at about $9 billion after the funding round. That figure may still change, according to one source.
Neuralink did not respond to Bloomberg‘s request for comment.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
